Skip to main content
Top
Published in: Clinical Rheumatology 1/2019

01-01-2019 | Original Article

The prevalence of dysphonia and dysphagia in patients affected by immunomediated diseases and the role of psychometric tests

Authors: J. Galli, M. R. Marchese, C. De Canio, M. Di Salvo, I. Olivieri, L. Santandrea, G. Paludetti

Published in: Clinical Rheumatology | Issue 1/2019

Login to get access

Abstract

This cross-sectional investigation examined the prevalence and severity of dysphonia, globus pharyngeus, and dysphagia in patients affected by immunomediated (IM) diseases. Seventy subjects were administered the Voice Handicap Index (VHI) (scale 0–4), Glasgow-Edinburgh Throat Scale (GETS) (scale from 0 to 7) for globus pharyngeus assessment, and modified Swallowing Outcomes After Revised Laryngectomy (SOAL) (scale 0, 1, 2) to test swallowing symptoms. VHI: the mean percentage of answers with a score greater than 1 (corresponding to a frequency of situation’s occurrence “sometimes,” “almost always,” or “always”) was 25.7, 26.7, and 44.1% for functional, emotional, and physical groups of sub-items respectively. GETS: the mean percentage of answers with a score ≥ 3 was 60.85%, significantly higher if compared with that of answers with a score < 3 (40.14%). The mean percentages of answers with a score 0–2, 3–4, and 5–7 were 40.1, 16.7, and 43.7% respectively. SOAL: a mean of 57.9% of answers gained a symptomatic score (1 [“a little”] or 2 [“a lot”]) and 41.9%, the score 0. The difference was statistically significant (p < 0.05). The first two most recurrent items with a score 2 (“a lot”) were “Do you have a problem swallowing dry food?” (46%) and “Do you have a problem swallowing solid food?” (36%). The study represents the first to describe the globus pharyngeus symptoms in IM population. Moreover, it allows to confirm the recurrence of dysphonia and dysphagia in this type of patients. Particularly, it has been demonstrated that the alteration of swallowing function is related to solid and dry food. The self-assessment questionnaires proved as a useful tool to early detection of dysfunctions in order to avoid further deterioration of quality of life and to prevent serious life-threatening complications.
Literature
1.
go back to reference Speyer R, Baijens L, Heijnen M, Zwijnenberg I (2010) Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia 25:40–65CrossRef Speyer R, Baijens L, Heijnen M, Zwijnenberg I (2010) Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia 25:40–65CrossRef
2.
go back to reference Chong VH, Wang CL (2008) Higher prevalence of gastrointestinal symptoms among patients with rheumatic disorders. Singap Med J 49:419–424 Chong VH, Wang CL (2008) Higher prevalence of gastrointestinal symptoms among patients with rheumatic disorders. Singap Med J 49:419–424
3.
go back to reference Joint Formulary Committee (2011) Section 10.1.3. British National Formulary, 62nd edn. BMJ Group and Pharmaceutical Press, London Joint Formulary Committee (2011) Section 10.1.3. British National Formulary, 62nd edn. BMJ Group and Pharmaceutical Press, London
4.
go back to reference Merrill RM, Anderson AE, Sloan A (2011) Quality of life indicators according to voice disorders and voice-related conditions. Laryngoscope 121:2004–2010PubMed Merrill RM, Anderson AE, Sloan A (2011) Quality of life indicators according to voice disorders and voice-related conditions. Laryngoscope 121:2004–2010PubMed
5.
go back to reference Hilgert E, Toleti B, Kruger K, Nejedlo I (2008) Hoarseness due to bamboo nodes in patients with autoimmune diseases: a review of literature. J Voice 22:343–350CrossRefPubMed Hilgert E, Toleti B, Kruger K, Nejedlo I (2008) Hoarseness due to bamboo nodes in patients with autoimmune diseases: a review of literature. J Voice 22:343–350CrossRefPubMed
6.
go back to reference Li H, Huang Z, Hu R, Zhang L, Xu W (2012) Study on the simplified Chinese version of the Voice Handicap Index. J Voice 26(3):365–371CrossRefPubMed Li H, Huang Z, Hu R, Zhang L, Xu W (2012) Study on the simplified Chinese version of the Voice Handicap Index. J Voice 26(3):365–371CrossRefPubMed
7.
go back to reference Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2004) Development and validation of the Voice Handicap Index–10. Laryngoscope 114:1549–1556CrossRefPubMed Rosen CA, Lee AS, Osborne J, Zullo T, Murry T (2004) Development and validation of the Voice Handicap Index–10. Laryngoscope 114:1549–1556CrossRefPubMed
8.
go back to reference Geterud A, Bake B, Bjelle A, Jonsson R, Sandberg N, Ejnell H (1991) Swallowing problems in rheumatoid arthritis. Acta Otolaryngol 111(6):1153–1161CrossRefPubMed Geterud A, Bake B, Bjelle A, Jonsson R, Sandberg N, Ejnell H (1991) Swallowing problems in rheumatoid arthritis. Acta Otolaryngol 111(6):1153–1161CrossRefPubMed
9.
go back to reference Palma R, Freire A, Freitas J, Morbey A, Costa T, Saraiva F, Queirós F, Carvalhinhos A (1994) Esophageal motility disorders in patients with Sjogren’s syndrome. Dig Dis Sci 39(4):758–761CrossRefPubMed Palma R, Freire A, Freitas J, Morbey A, Costa T, Saraiva F, Queirós F, Carvalhinhos A (1994) Esophageal motility disorders in patients with Sjogren’s syndrome. Dig Dis Sci 39(4):758–761CrossRefPubMed
10.
go back to reference Tsianos EB, Chiras CD, Drosos AA, Moutsopoulos HM (1985) Oesophageal dysfunction in patients with primary Sjogren’s syndrome. Ann Rheum Dis 44(9):610–613CrossRefPubMedPubMedCentral Tsianos EB, Chiras CD, Drosos AA, Moutsopoulos HM (1985) Oesophageal dysfunction in patients with primary Sjogren’s syndrome. Ann Rheum Dis 44(9):610–613CrossRefPubMedPubMedCentral
11.
go back to reference Turk T, Piriladar T, Tunc E, Bor S, Dogananvasargil E (2005) Manometric assessment of esophageal motility in patients with primary Sjogren’s syndrome. Rheumatol Int Clin Exp Invest 25(4):246–249CrossRef Turk T, Piriladar T, Tunc E, Bor S, Dogananvasargil E (2005) Manometric assessment of esophageal motility in patients with primary Sjogren’s syndrome. Rheumatol Int Clin Exp Invest 25(4):246–249CrossRef
12.
go back to reference Lofgren R, Montgomery W (1962) Incidence of laryngeal involvement in rheumatoid arthritis. N Engl J Med 267:193–195CrossRefPubMed Lofgren R, Montgomery W (1962) Incidence of laryngeal involvement in rheumatoid arthritis. N Engl J Med 267:193–195CrossRefPubMed
13.
go back to reference Ekberg O, Redlund-Johnell I, Sjoblom KG (1987) Pharyngeal function in patients with rheumatoid arthritis of the cervical spine and temporomandibular joint. Acta Radiol 28(1):35–39CrossRefPubMed Ekberg O, Redlund-Johnell I, Sjoblom KG (1987) Pharyngeal function in patients with rheumatoid arthritis of the cervical spine and temporomandibular joint. Acta Radiol 28(1):35–39CrossRefPubMed
14.
go back to reference Soares RV, Forsythe A, Hogarth K, Sweiss NJ, Noth I, Patti MG (2011) Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. Arq Gastroenterol 48:91–97CrossRefPubMed Soares RV, Forsythe A, Hogarth K, Sweiss NJ, Noth I, Patti MG (2011) Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment. Arq Gastroenterol 48:91–97CrossRefPubMed
15.
go back to reference Jacobson BH, Johnson A, Grywalski A, Silbergeit A, Jacobson G, Benninger MS et al (1997) The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70CrossRef Jacobson BH, Johnson A, Grywalski A, Silbergeit A, Jacobson G, Benninger MS et al (1997) The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70CrossRef
16.
go back to reference Arffa RE, Krishna P, Gartner-Shmidt J, Rosen C (2012) Normative values for Voice Handicap Index-10. J Voice 26(4):462–465CrossRefPubMed Arffa RE, Krishna P, Gartner-Shmidt J, Rosen C (2012) Normative values for Voice Handicap Index-10. J Voice 26(4):462–465CrossRefPubMed
17.
go back to reference Wallace KL, Middleton S, Cook J (2000) Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology 118(4):678–687CrossRef Wallace KL, Middleton S, Cook J (2000) Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology 118(4):678–687CrossRef
18.
go back to reference Govender R, Lee MT, Drinnan M, Davies T, Twinn C, Hilari K (2016) Psychometric evaluation of the Swallowing Outcome After Laryngectomy (SOAL) patient reported outcome measure. Head Neck 38(Suppl 1):E1639–E1645CrossRefPubMed Govender R, Lee MT, Drinnan M, Davies T, Twinn C, Hilari K (2016) Psychometric evaluation of the Swallowing Outcome After Laryngectomy (SOAL) patient reported outcome measure. Head Neck 38(Suppl 1):E1639–E1645CrossRefPubMed
19.
go back to reference Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW (2012) Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 21(4):651–657CrossRef Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW (2012) Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 21(4):651–657CrossRef
20.
go back to reference Amos J, Baron A, Rubin AD (2016) Autoimmune swallowing disorders. Curr Opin Otolaryngol Head Neck Surg 24:483–488CrossRefPubMed Amos J, Baron A, Rubin AD (2016) Autoimmune swallowing disorders. Curr Opin Otolaryngol Head Neck Surg 24:483–488CrossRefPubMed
21.
go back to reference Preouse R, Coulombeau B, Cornut G, Bouchayer M (2001) “Bamboo nodes”: a clinical study of 19 cases. Rev Laryngol Otol Rhinol (Bord) 122:299–302 Preouse R, Coulombeau B, Cornut G, Bouchayer M (2001) “Bamboo nodes”: a clinical study of 19 cases. Rev Laryngol Otol Rhinol (Bord) 122:299–302
22.
go back to reference Hosako-NaitoY,TayamaN, NiimiS et al (1999) Diagnosis and physiopathology of laryngeal deposits in autoimmune disease. ORL J Otorhinolaryngol Relat Spec 61:151–157CrossRef Hosako-NaitoY,TayamaN, NiimiS et al (1999) Diagnosis and physiopathology of laryngeal deposits in autoimmune disease. ORL J Otorhinolaryngol Relat Spec 61:151–157CrossRef
23.
go back to reference Ylitalo R, Heimburger M, Lindestad PA (2003) Vocal fold deposits in autoimmune disease—an unusual cause of hoarseness. Clin Otolaryngol Allied Sci 28:446–450CrossRefPubMed Ylitalo R, Heimburger M, Lindestad PA (2003) Vocal fold deposits in autoimmune disease—an unusual cause of hoarseness. Clin Otolaryngol Allied Sci 28:446–450CrossRefPubMed
24.
go back to reference Murano E, Hosako-Naito Y, Tayama N, Oka T, Miyaji M, Kumada M, Niimi S (2001) Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice 15:441–450CrossRefPubMed Murano E, Hosako-Naito Y, Tayama N, Oka T, Miyaji M, Kumada M, Niimi S (2001) Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice 15:441–450CrossRefPubMed
25.
go back to reference Ruiz Allec LD, Hernandez Lopez X, Arreguın Porras JB, Velasco Ramos R, Pacheco del Valle JC, Perez Garcia AI (2011) Alterations in voice, speech and swallowing in patients with Sjogren’s syndrome. Acta Otorrinolaringol Esp 62:255–264CrossRefPubMed Ruiz Allec LD, Hernandez Lopez X, Arreguın Porras JB, Velasco Ramos R, Pacheco del Valle JC, Perez Garcia AI (2011) Alterations in voice, speech and swallowing in patients with Sjogren’s syndrome. Acta Otorrinolaringol Esp 62:255–264CrossRefPubMed
26.
27.
go back to reference Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT (2007) Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjogren’s syndrome. Scand J Rheumatol 36:394–401CrossRefPubMed Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT (2007) Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjogren’s syndrome. Scand J Rheumatol 36:394–401CrossRefPubMed
28.
go back to reference Groher ME, Bukatman R (1986) The prevalence of swallowing disorders in two teaching hospitals. Dysphagia 1(1):3–6CrossRef Groher ME, Bukatman R (1986) The prevalence of swallowing disorders in two teaching hospitals. Dysphagia 1(1):3–6CrossRef
29.
go back to reference Govender R, Lee MT, Davies TC, Twinn CE, Katsoulis KL, Payten CL, Stephensk R, Drinnan M (2012) Development and preliminary validation of a patient-reported outcome measure for swallowing after total laryngectomy (SOAL questionnaire). Clin Otolaryngol 37:452–459CrossRefPubMed Govender R, Lee MT, Davies TC, Twinn CE, Katsoulis KL, Payten CL, Stephensk R, Drinnan M (2012) Development and preliminary validation of a patient-reported outcome measure for swallowing after total laryngectomy (SOAL questionnaire). Clin Otolaryngol 37:452–459CrossRefPubMed
30.
go back to reference Al-Adhadh RN, Al-Sayed TA (2001) Clinical features of systemic sclerosis. Saudi Med J 22:333–336PubMed Al-Adhadh RN, Al-Sayed TA (2001) Clinical features of systemic sclerosis. Saudi Med J 22:333–336PubMed
31.
go back to reference Fitzgerald RC, Triadafilopoulos G (1997) Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum 26:641–666CrossRefPubMed Fitzgerald RC, Triadafilopoulos G (1997) Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum 26:641–666CrossRefPubMed
32.
go back to reference Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD (2011) Gastrointestinal manifestations in systemic autoimmune diseases. Maedica (Buchar) 6:45–51 Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD (2011) Gastrointestinal manifestations in systemic autoimmune diseases. Maedica (Buchar) 6:45–51
33.
go back to reference Sheehan NJ (2008) Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases. Rheumatology (Oxford) 47:746–752CrossRef Sheehan NJ (2008) Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases. Rheumatology (Oxford) 47:746–752CrossRef
34.
go back to reference Eyigör S (2013) Dysphagia in rheumatological disorders. World J Rheumatol 3(3):45–50CrossRef Eyigör S (2013) Dysphagia in rheumatological disorders. World J Rheumatol 3(3):45–50CrossRef
35.
go back to reference Rosas J, Ramos M, García M, Carrasco J, Mun ̃oz E, Pascual E (2002) Afectación oral. In: Ramos-Cassals M, García-Carrasco M, Anaya M, Coll J, Cervera R, Font J et al (eds) Síndrome de Sjögren. Barcelona, Masson, pp 139–155 Rosas J, Ramos M, García M, Carrasco J, Mun ̃oz E, Pascual E (2002) Afectación oral. In: Ramos-Cassals M, García-Carrasco M, Anaya M, Coll J, Cervera R, Font J et al (eds) Síndrome de Sjögren. Barcelona, Masson, pp 139–155
36.
go back to reference Ertekin C, Secil Y, Yuceyar N et al (2004) Oropharyngeal dysphagia in polymyositis/dermatomyositis. Clin Neurol Neurosurg 107:32–37CrossRefPubMed Ertekin C, Secil Y, Yuceyar N et al (2004) Oropharyngeal dysphagia in polymyositis/dermatomyositis. Clin Neurol Neurosurg 107:32–37CrossRefPubMed
37.
go back to reference Deary IJ, Wilson JA, Kelly SW (1995) Globus pharyngis, personality, and psychological distress in the general population. Psychosomatics 36:570–577CrossRefPubMed Deary IJ, Wilson JA, Kelly SW (1995) Globus pharyngis, personality, and psychological distress in the general population. Psychosomatics 36:570–577CrossRefPubMed
39.
go back to reference Pierce JL, Tanner K, Ray M, Merrill RM, Miller KL, Kendall KA, Roy N (2016) Swallowing disorders in Sjogren’s syndrome: prevalence, risk factors, and effects on quality of life. Dysphagia 31:49–59CrossRefPubMed Pierce JL, Tanner K, Ray M, Merrill RM, Miller KL, Kendall KA, Roy N (2016) Swallowing disorders in Sjogren’s syndrome: prevalence, risk factors, and effects on quality of life. Dysphagia 31:49–59CrossRefPubMed
40.
go back to reference Hill J, Stuart RC, Fung HK, Ng EKW, Cheung FM, Chung SCS, Andrew van Hasselt C (1997) Gastroesophageal reflux, motility disorders and psychological profiles in the etiology of globus pharyngis. Laryngoscope 107:1373–1377CrossRefPubMed Hill J, Stuart RC, Fung HK, Ng EKW, Cheung FM, Chung SCS, Andrew van Hasselt C (1997) Gastroesophageal reflux, motility disorders and psychological profiles in the etiology of globus pharyngis. Laryngoscope 107:1373–1377CrossRefPubMed
41.
go back to reference Sanz L, Sistiaga JA, Lara AJ, Cuende E, Garcia-Alcantara Fand Rivera T (2012) The prevalence of dysphonia, its association with immunomediated diseases and correlation with biochemical markers. J Voice 26(2):148–153CrossRefPubMed Sanz L, Sistiaga JA, Lara AJ, Cuende E, Garcia-Alcantara Fand Rivera T (2012) The prevalence of dysphonia, its association with immunomediated diseases and correlation with biochemical markers. J Voice 26(2):148–153CrossRefPubMed
42.
go back to reference Roy N, Merrill RM, Gray SD, Smith EM (2005) Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope 115:1988–1995CrossRefPubMed Roy N, Merrill RM, Gray SD, Smith EM (2005) Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope 115:1988–1995CrossRefPubMed
43.
go back to reference Speyer R, Speyer I, Heijnen AM (2008) Prevalence and relative risk of dysphonia in rheumatoid arthritis. J Voice 22:232–238CrossRefPubMed Speyer R, Speyer I, Heijnen AM (2008) Prevalence and relative risk of dysphonia in rheumatoid arthritis. J Voice 22:232–238CrossRefPubMed
44.
go back to reference Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157(5, pt 1):1658–1665CrossRefPubMed Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157(5, pt 1):1658–1665CrossRefPubMed
45.
go back to reference Schwemmle C, Kreipe HH, Witte T, Ptok M (2013) Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness. Rheumatol Int 33(3):777–781CrossRefPubMed Schwemmle C, Kreipe HH, Witte T, Ptok M (2013) Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness. Rheumatol Int 33(3):777–781CrossRefPubMed
46.
go back to reference Berjawi G, Uthman I, Mahfoud L, Husseini ST, Nassar J, Kotobi A, Hamdan ALH (2010) Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice 24:732–737CrossRefPubMed Berjawi G, Uthman I, Mahfoud L, Husseini ST, Nassar J, Kotobi A, Hamdan ALH (2010) Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice 24:732–737CrossRefPubMed
Metadata
Title
The prevalence of dysphonia and dysphagia in patients affected by immunomediated diseases and the role of psychometric tests
Authors
J. Galli
M. R. Marchese
C. De Canio
M. Di Salvo
I. Olivieri
L. Santandrea
G. Paludetti
Publication date
01-01-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4129-8

Other articles of this Issue 1/2019

Clinical Rheumatology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.